Literature DB >> 19380788

The regulation of liver cell survival by complement.

Maciej M Markiewski1, Robert A DeAngelis, Christoph W Strey, Periklis G Foukas, Craig Gerard, Norma Gerard, Rick A Wetsel, John D Lambris.   

Abstract

Complement effectors are known to contribute to host cell injury in several inflammatory diseases. Contrary to this paradigm, in this study utilizing surgical liver resection (partial hepatectomy) in various complement-deficient mice as a model, we have demonstrated that complement anaphylatoxins C3a and C5a are required for the survival of liver cells during regeneration. The mechanisms of these cytoprotective functions of complement were related to the regulation of IL-6 and TNF production or release after liver resection. Disturbances in the cytokine milieu, induced by a loss of complement activity, were found to alter prosurvival signaling, including the IL-6/STAT3 and PI3K/Akt/mammalian target of rapamycin pathways. In conclusion, this study documents functions of complement proteins as prosurvival factors that, through their interactions with cytokines, inhibit apoptotic signaling in proliferating cells of epithelial origin.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19380788      PMCID: PMC2732128          DOI: 10.4049/jimmunol.0804179

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  32 in total

Review 1.  Complement. Second of two parts.

Authors:  M J Walport
Journal:  N Engl J Med       Date:  2001-04-12       Impact factor: 91.245

Review 2.  Complement. First of two parts.

Authors:  M J Walport
Journal:  N Engl J Med       Date:  2001-04-05       Impact factor: 91.245

3.  Cutting edge: targeted disruption of the C3a receptor gene demonstrates a novel protective anti-inflammatory role for C3a in endotoxin-shock.

Authors:  J Kildsgaard; T J Hollmann; K W Matthews; K Bian; F Murad; R A Wetsel
Journal:  J Immunol       Date:  2000-11-15       Impact factor: 5.422

4.  Complement in inflammatory tissue damage and disease.

Authors:  Tom E Mollnes; Wen-Chao Song; John D Lambris
Journal:  Trends Immunol       Date:  2002-02       Impact factor: 16.687

Review 5.  Coordinate regulation of translation by the PI 3-kinase and mTOR pathways.

Authors:  Kathleen A Martin; John Blenis
Journal:  Adv Cancer Res       Date:  2002       Impact factor: 6.242

Review 6.  The phosphatidylinositol 3-Kinase AKT pathway in human cancer.

Authors:  Igor Vivanco; Charles L Sawyers
Journal:  Nat Rev Cancer       Date:  2002-07       Impact factor: 60.716

Review 7.  Points of control in inflammation.

Authors:  Carl Nathan
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

8.  A novel role of complement: mice deficient in the fifth component of complement (C5) exhibit impaired liver regeneration.

Authors:  D Mastellos; J C Papadimitriou; S Franchini; P A Tsonis; J D Lambris
Journal:  J Immunol       Date:  2001-02-15       Impact factor: 5.422

9.  Normal liver regeneration in p50/nuclear factor kappaB1 knockout mice.

Authors:  R A DeAngelis; K Kovalovich; D E Cressman; R Taub
Journal:  Hepatology       Date:  2001-04       Impact factor: 17.425

10.  Rapid activation of protein kinase B/Akt has a key role in antiapoptotic signaling during liver regeneration.

Authors:  F Hong; V A Nguyen; X Shen; G Kunos; B Gao
Journal:  Biochem Biophys Res Commun       Date:  2000-12-29       Impact factor: 3.575

View more
  43 in total

Review 1.  Dynamic control of the complement system by modulated expression of regulatory proteins.

Authors:  Joshua M Thurman; Brandon Renner
Journal:  Lab Invest       Date:  2010-10-04       Impact factor: 5.662

Review 2.  Complement: a key system for immune surveillance and homeostasis.

Authors:  Daniel Ricklin; George Hajishengallis; Kun Yang; John D Lambris
Journal:  Nat Immunol       Date:  2010-08-19       Impact factor: 25.606

Review 3.  Complement activation in the context of stem cells and tissue repair.

Authors:  Ingrid U Schraufstatter; Sophia K Khaldoyanidi; Richard G DiScipio
Journal:  World J Stem Cells       Date:  2015-09-26       Impact factor: 5.326

4.  CR2+ marginal zone B cell production of pathogenic natural antibodies is C3 independent.

Authors:  Keith M Woods; Michael R Pope; Sara M Hoffman; Sherry D Fleming
Journal:  J Immunol       Date:  2010-12-27       Impact factor: 5.422

5.  Complement activation in acetaminophen-induced liver injury in mice.

Authors:  Rohit Singhal; Patricia E Ganey; Robert A Roth
Journal:  J Pharmacol Exp Ther       Date:  2012-02-07       Impact factor: 4.030

Review 6.  Interactions between coagulation and complement--their role in inflammation.

Authors:  Katerina Oikonomopoulou; Daniel Ricklin; Peter A Ward; John D Lambris
Journal:  Semin Immunopathol       Date:  2011-08-03       Impact factor: 9.623

7.  The intrinsic complement regulator decay-accelerating factor modulates the biological response to vascular injury.

Authors:  Masashi Sakuma; Toshifumi Morooka; Yunmei Wang; Can Shi; Kevin Croce; Huiyun Gao; Michael Strainic; M Edward Medof; Daniel I Simon
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-03-18       Impact factor: 8.311

8.  The receptor for the complement C3a anaphylatoxin (C3aR) provides host protection against Listeria monocytogenes-induced apoptosis.

Authors:  Stacey L Mueller-Ortiz; John E Morales; Rick A Wetsel
Journal:  J Immunol       Date:  2014-06-30       Impact factor: 5.422

9.  Human mannose-binding lectin inhibitor prevents myocardial injury and arterial thrombogenesis in a novel animal model.

Authors:  Vasile I Pavlov; Ying S Tan; Erin E McClure; Laura R La Bonte; Chenhui Zou; William B Gorsuch; Gregory L Stahl
Journal:  Am J Pathol       Date:  2014-12-04       Impact factor: 4.307

Review 10.  The complement cascade as a mediator of tissue growth and regeneration.

Authors:  Martin J Rutkowski; Michael E Sughrue; Ari J Kane; Brian J Ahn; Shanna Fang; Andrew T Parsa
Journal:  Inflamm Res       Date:  2010-06-02       Impact factor: 4.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.